Pfizer SEC Filings

Type
Report
Date
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/3/2026
4Insidertransaktion2/2/2026
4Insidertransaktion1/16/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion1/5/2026
4Insidertransaktion12/17/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/16/2025
4Insidertransaktion12/2/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/21/2025
424B5424B5-Formular11/20/2025
FWPFWP-Formular11/19/2025
424B3424B3-Formular11/18/2025
4Insidertransaktion11/17/2025
13F-HR13F-HR-Formular11/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/4/2025
10-QQuartalsbericht11/4/2025
4Insidertransaktion11/3/2025
4Insidertransaktion10/17/2025
4Insidertransaktion10/16/2025
4Insidertransaktion10/2/2025
4Insidertransaktion10/2/2025
4Insidertransaktion10/2/2025
4Insidertransaktion10/2/2025
4Insidertransaktion10/2/2025
4Insidertransaktion10/2/2025
4Insidertransaktion9/17/2025
4Insidertransaktion9/3/2025
4Insidertransaktion8/19/2025
13F-HR13F-HR-Formular8/11/2025
10-QQuartalsbericht8/5/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/5/2025
4Insidertransaktion8/4/2025
4Insidertransaktion7/16/2025
4Insidertransaktion7/2/2025
4Insidertransaktion7/2/2025
4Insidertransaktion7/2/2025
4Insidertransaktion7/2/2025
4Insidertransaktion7/2/2025
4Insidertransaktion7/2/2025
4Insidertransaktion6/17/2025
11-K11-K-Formular6/16/2025
11-K11-K-Formular6/16/2025
4Insidertransaktion6/3/2025
SDSD-Formular5/30/2025
144144-Formular5/23/2025
CERTCERT-Formular5/20/2025
8-A12B8-A12B-Formular5/19/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/19/2025
4Insidertransaktion5/19/2025
424B5424B5-Formular5/15/2025
FWPFWP-Formular5/14/2025
POSASRPOSASR-Formular5/13/2025
13F-HR13F-HR-Formular5/13/2025
424B3424B3-Formular5/13/2025
144144-Formular5/5/2025
10-QQuartalsbericht5/5/2025
4Insidertransaktion5/2/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/29/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/28/2025
4Insidertransaktion4/17/2025
4Insidertransaktion4/14/2025
DEFA14ADEFA14A-Formular4/11/2025
DEFA14ADEFA14A-Formular4/10/2025
DEFA14ADEFA14A-Formular4/10/2025
DEFA14ADEFA14A-Formular4/10/2025
DEFA14ADEFA14A-Formular4/7/2025
4Insidertransaktion4/2/2025
4Insidertransaktion4/2/2025
4Insidertransaktion4/2/2025
4Insidertransaktion4/2/2025
4Insidertransaktion4/2/2025
4Insidertransaktion4/2/2025
PX14A6GPX14A6G-Formular3/25/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular3/24/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular3/20/2025
4Insidertransaktion3/18/2025
DEF 14ADEF 14A-Formular3/13/2025
ARSARS-Formular3/13/2025
DEFA14ADEFA14A-Formular3/13/2025
4Insidertransaktion3/6/2025
4Insidertransaktion3/6/2025
4Insidertransaktion3/6/2025

Pfizer Documents 2026

This page contains all official documents and SEC filings for Pfizer stock (PFE, ISIN: US7170811035). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Pfizer's regulatory filings.

Pfizer Stock analysis

Pfizer Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries. Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry. In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products. Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products. Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products. Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures. In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness. Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products. In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives.